Target Group Inc. SEC filings CBDY
Target Group Inc. has 254 filings in SEC EDGAR's recent list, going back to Sep 30, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 18, 2025 (new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14C | Information statement | Sep 4, 2018 | Sep 4, 2018 |
| PRE 14C | Filing | Aug 21, 2018 | Aug 21, 2018 |
| DEF 14C | Information statement | Oct 10, 2017 | Sep 28, 2017 |
| PRE 14C | Filing | Sep 18, 2017 | Sep 18, 2017 |
| PRE 14C | Filing | May 30, 2017 | May 30, 2017 |
| DEF 14C | Information statement | Feb 14, 2017 | Feb 14, 2017 |
| PRE 14C | Filing | Feb 3, 2017 | Feb 3, 2017 |
| DEF 14C | Information statement | Sep 27, 2016 | Sep 27, 2016 |
| PRE 14C | Preliminary information statement | Sep 15, 2016 | Sep 27, 2016 |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CBDY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hamilton
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1586554
- Former names
- Chess Supersite Corp (until Jul 3, 2018); River Run Acquisition Corp (until May 13, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.